Standard Nuclear Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Revenue	7.54	3.14	-
Revenue Growth	-	-	-
Cost of Revenue	11.89	7.67	-
Gross Profit	-4.35	-4.53	-
Selling, General & Admin	12.21	4.5	1.34
Research & Development	1.96	-	60.6
Operating Expenses	14.17	4.5	61.94
Operating Income	-18.52	-9.03	-61.94
Interest & Investment Income	1.77	0.36	-
Other Non Operating Income (Expenses)	-0.01	-7.73	-51.26
EBT Excluding Unusual Items	-16.76	-16.39	-113.19
Other Unusual Items	-	0.85	-
Pretax Income	-16.76	-15.54	-113.19
Net Income	-16.76	-15.54	-113.19
Net Income to Common	-16.76	-15.54	-113.19
Net Income Growth	-	-	-
Shares Outstanding (Basic)	28	28	13
Shares Outstanding (Diluted)	28	28	13
Shares Change	-	123.68%	-
EPS (Basic)	-0.60	-0.56	-9.04
EPS (Diluted)	-0.61	-0.56	-9.04
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Free Cash Flow	-40.7	-15.66	-5.14
Free Cash Flow Per Share	-1.45	-0.56	-0.41
Gross Margin	-57.75%	-144.36%	-
Operating Margin	-245.67%	-287.65%	-
Profit Margin	-222.32%	-494.92%	-
Free Cash Flow Margin	-539.91%	-498.71%	-
EBITDA	-17.63	-8.68	-61.93
EBITDA Margin	-233.84%	-276.47%	-
D&A For EBITDA	0.89	0.35	0
EBIT	-18.52	-9.03	-61.94
EBIT Margin	-245.67%	-287.65%	-
Revenue as Reported	7.54	3.14	-

SEC Filings: 10-K · 10-Q